Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management

Frontiers in Endocrinology

Luigi Barrea¹  Giovanni Vitale¹  Barbara Altieri¹  Pasquale Malandrino¹  Alessandra Dicitore¹  Paola Razzore¹  Laura Rizza¹  Elia Guadagno¹  Andrea Lenzi¹  Mary Anna Venneri¹  NIKE Group¹  Filomena Bottiglieri¹  Federica de Cicco¹  Elisa Giannetta¹  Andrea Lania¹  Roberta Modica¹  Giovanna Muscogiuri¹  Manuela Albertelli¹  Fabio Lo Calzo¹  Erika Grossrubatscher¹  Francesco Ferraù¹  Rosa Maria Ruggieri¹  Emilia Sbardella¹  Genoveffa Pizza¹  Valentina Guarnotta¹  Carmen Rainone¹  Manila Rubino¹  Andrea M. Isidori¹  Diego Ferone¹  Maria Chiara Zatelli¹  Riccardo Pofi¹  Marco Gallo¹  Federica Grillo¹  Erika Messina¹  Giulia Puliani¹  Franz Sesti¹  Severo Campione¹  Andrea Dotto³  Annamaria Colao⁴  Antongiulio Faggiano⁵  Tullio Florio⁷  Giuseppe Fanciulli⁸  Tiziana Feola⁹  Sergio Di Molfetta^1,10 

[1] ;Department of Experimental Medicine, “Sapienza” University of Rome, Rome, Italy;Department of Internal Medicine, University of Genova, Genova, Italy;Endocrinology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy;Endocrinology Unit, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy;Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy;IRCCS Ospedale Policlinico San Martino, Genova, Italy;NET Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari—Endocrinology Unit, Sassari, Italy;Neuroendocrinology, Neuromed Institute, IRCCS, Pozzilli, Italy;Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy;

关键词: parathyroid carcinoma;    immune checkpoint inhibitors;    ipilimumab;    nivolumab;    pembrolizumab;   

DOI  :  10.3389/fendo.2021.700806

来源: DOAJ

【 授权许可】

Unknown